Venlafaxin Krka Hart forðahylki 37,5 mg Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxin krka hart forðahylki 37,5 mg

krka sverige ab - venlafaxinum hýdróklóríð - hart forðahylki - 37,5 mg

Venlafaxin Krka Hart forðahylki 75 mg Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxin krka hart forðahylki 75 mg

krka sverige ab - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg

Venlafaxin Medical Valley Forðatafla 225 mg Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxin medical valley forðatafla 225 mg

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 225 mg

Tremfya Unia Europejska - islandzki - EMA (European Medicines Agency)

tremfya

janssen-cilag international nv - guselkumab - psoriasis - Ónæmisbælandi lyf - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.

Besremi Unia Europejska - islandzki - EMA (European Medicines Agency)

besremi

aop orphan pharmaceuticals gmbh - ropeginterferon alfa-2b - blóðríki - Ónæmisörvandi, - besremi er ætlað eitt og sér í fullorðnir fyrir meðferð polycythaemia vera án einkenna miltisstækkun.

Givlaari Unia Europejska - islandzki - EMA (European Medicines Agency)

givlaari

alnylam netherlands b.v. - givosiran - porphyrias, lifur - Ýmsum meltingarvegi og efnaskipti vörur - meðferð bráð lifur porfýría (wells fargo) í fullorðnir og unglingar á aldrinum 12 ára og eldri.

Calquence Unia Europejska - islandzki - EMA (European Medicines Agency)

calquence

astrazeneca ab - acalabrutinib - kyrningahvítblæði, eitilfrumnafæð, langvarandi, b-frumur - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

Rayvow Unia Europejska - islandzki - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - mígreni kvilla - verkjalyf - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.